Cytokine Based Drug Development Webinar
Despite some high-profile setbacks and dropped assets, the cytokine drug-development landscape continues to flourish. In our exclusive webinar, our expert panel delved into the landscape, showcased the shift in targets, and assessed the effect of the continued challenges being faced by drug developers, to provide an extensive analysis of the dynamic landscape. Key aspects explored included:
A comprehensive overview of the evolving landscape, including cytokines as monotherapies and in combinations
Insights into the emerging trends of interleukin targets, including IL-2, IL-7, and IL-12
A picture of what we can likely expect ahead based on drugs that have been translated into the clinic so far this year.
Our Experts
Aysha Saeed
House Speaker
Lead Research Analyst
Beacon
Priya Soneji
Moderator
Account Manager
Beacon
You May Also Be Interested In…
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
